Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-09-27
1985-09-24
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548309, A61K 31415
Patent
active
045433593
ABSTRACT:
Dantrolene sodium is useful as a cardiac antiarrhythmic agent in hypothermic and normothermic warm-blooded animals.
REFERENCES:
Malloy, K., Ph.D. Thesis, Univ. of Rochester, 1981.
Dissertation Abstracts International, 42(8), 3222-B, (1982), [Salata, J., Ph.D. Thesis, 1981].
Dissertation Abstracts International, 42(4), 1337-B, (1981), [Malloy, K., PH.D. Thesis, 1981].
Salata, J. et al., J. Pharmacol. Exp. Ther., 220(1), 157-166, (1982).
Ellis Keith O.
Moore Alan F.
Eaton Laboratories, Inc.
Graff IV Milton B.
Schaeffer Jack D.
Schwartz Richard A.
Witte Richard C.
LandOfFree
Treating cardiac arrhythmias with dantrolene sodium does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating cardiac arrhythmias with dantrolene sodium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating cardiac arrhythmias with dantrolene sodium will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1614445